Related references
Note: Only part of the references are listed.Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers
Libo Yang et al.
CANCER SCIENCE (2019)
ZNF277 regulates ovarian cancer cell proliferation and invasion through inhibition of PTEN
Zhengling Liu et al.
ONCOTARGETS AND THERAPY (2019)
Early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer
Hiroki Osumi et al.
SCIENTIFIC REPORTS (2019)
Immunotherapy and targeted therapy-the new roadmap in cancer treatment
Kamran Shahid et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
A four-mRNA model to improve the prediction of breast cancer prognosis
Lingyu Qi et al.
GENE (2019)
3.5KJPNv2: an allele frequency panel of 3552 Japanese individuals including the X chromosome
Shu Tadaka et al.
HUMAN GENOME VARIATION (2019)
The clinical significance of COL5A2 in patients with bladder cancer: A retrospective analysis of bladder cancer gene expression data
Xian-Tao Zeng et al.
MEDICINE (2018)
Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice
Tindaro Giardina et al.
PATHOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
TNFRSF10C methylation is a new epigenetic biomarker for colorectal cancer
Cong Zhou et al.
PEERJ (2018)
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
S. Lheureux et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Carbonic anhydrase XII functions in health and disease
Abdul Waheed et al.
GENE (2017)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
Genetic effects on gene expression across human tissues
Francois Aguet et al.
NATURE (2017)
In a major shift, cancer drugs go 'tissue-agnostic'
Ken Garber
SCIENCE (2017)
Role of Chemotherapy and Radiation Therapy in the Management of Gastric Adenocarcinoma
Daphna Spiegel et al.
SURGICAL CLINICS OF NORTH AMERICA (2017)
Prevalence and detection of low-allele-fraction variants in clinical cancer samples
Hyun-Tae Shin et al.
NATURE COMMUNICATIONS (2017)
DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma
Min Yuen Teo et al.
CLINICAL CANCER RESEARCH (2017)
Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Prithviraj Bose et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
An update of current treatments for adult acute myeloid leukemia
Herve Dombret et al.
BLOOD (2016)
Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes
D. A. Sallman et al.
LEUKEMIA (2016)
Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment
Renato Bassan et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Human genetic variation database, a reference database of genetic variations in the Japanese population
Koichiro Higasa et al.
JOURNAL OF HUMAN GENETICS (2016)
Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer
Walid L. Shaib et al.
ONCOLOGIST (2016)
Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines
Radoslaw Januchowski et al.
JOURNAL OF CANCER (2016)
Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence
Brooke L. Fridley et al.
FRONTIERS IN GENETICS (2016)
Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?
Andrea Botticelli et al.
PLOS ONE (2016)
Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients
Chen-Yue Qian et al.
CHINESE JOURNAL OF CANCER (2016)
Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts
John W. Cassidy et al.
CANCER RESEARCH (2015)
Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells
Joanna Kopecka et al.
ONCOTARGET (2015)
Colorectal cancer
Ernst J. Kuipers et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression
Ana Cristina Vargas et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
NYAP: a phosphoprotein family that links PI3K to WAVE1 signalling in neurons
Kazumasa Yokoyama et al.
EMBO JOURNAL (2011)
Assessment of the Evolution of Cancer Treatment Therapies
Manuel Arruebo et al.
Cancers (2011)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin
David E. Joyner et al.
FAMILIAL CANCER (2009)
Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level
Donia P. Macartney-Coxson et al.
BMC CANCER (2008)
Identification of two novel polycystic kidney disease-1-like genes in human and mouse genomes
AR Li et al.
GENOMICS (2003)
Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2
H Fischer et al.
CARCINOGENESIS (2001)
Share Paper
